Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · IEX Real-Time Price · USD
2.210
+0.480 (27.75%)
At close: Jul 26, 2024, 4:00 PM
2.100
-0.110 (-4.98%)
After-hours: Jul 26, 2024, 7:10 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $80.39 million as of July 26, 2024. Its market cap has decreased by -78.35% in one year.
Market Cap
80.39M
Enterprise Value
75.66M
1-Year Change
-78.35%
Ranking
Category
Stock Price
$2.21
Market Cap Chart
Since July 15, 2021, Estrella Immunopharma's market cap has increased from $52.70M to $80.39M, an increase of 52.55%. That is a compound annual growth rate of 14.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 62.20M | 59.08% |
| Dec 29, 2023 | 39.10M | -35.05% |
| Dec 30, 2022 | 60.20M | 3.79% |
| Dec 31, 2021 | 58.00M | 10.06% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mural Oncology | 58.39M |
| Turnstone Biologics | 57.36M |
| Neuronetics | 57.30M |
| vTv Therapeutics | 57.20M |
| Barinthus Biotherapeutics | 56.48M |
| Allurion Technologies | 55.87M |
| VSee Lab/iDoc Virtual Telehealth Solutions, Inc. | 55.76M |
| Cytosorbents | 55.66M |